Vaccines

Bovine Viral Diarrhea Virus: Diagnosis, Management, and Control

Volumn , Issue , 2008, Pages 209-222

  Fulton, Robert W ^a  

^a OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

Diversity; Fetuses; Prevention; Vaccines; Virus strains

Indexed keywords

EID: 84889292800     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470344453.ch13     Document Type: Chapter

References (79)

1. Baker JC: 1987, Bovine viral diarrhea virus: a review. J Am Vet Med Assoc 190:1449-1458.
2. Barkema HW, Bartels CJ, van Wuijckhuise L, et al.: 2001, Outbreak of bovine virus diarrhea on Dutch dairy farms induced by a bovine herpesvirus 1 marker vaccine contaminated with bovine virus diarrhea virus type 2. Tijdschr Diergeneeskd 126:158-165.
3. Baxi MK, Deregt D, Robertson J, et al.: 2000, Recombinant bovine adenovirus type 3 expressing bovine viral diarrhea virus glycoprotein E2 induces an immune response in cotton rats. Virology 278:234-243.
4. Beer M, Hehnen HR, Wolfmeyer A, et al.: 2000, A new inactivated BVDV genotype I and II vaccine. An immunization and challenge study with BVDV genotype I. Vet Microbiol 77:195-208.
5. Beer M, Wolf G, Pickler J, et al.: 1997, Cytotoxic Tlymphocyte responses in cattle infected with bovine viral diarrhea virus. Vet Microbiol 58:9-22.
6. Bittle, JL.: 1968, Vaccination for bovine viral diarrheamucosal disease. J Am Vet Med Assoc 152:861.
7. Bolin SR: 1988, Viral and viral protein specificity of antibodies induced in cows persistently infected with noncytopathic bovine viral diarrhea virus after vaccination with cytopathic bovine viral diarrhea virus. Am J Vet Res 49:1040-1044.
8. Bolin SR: 1995, Control of bovine viral diarrhea infection by use of vaccination. Vet Clin North Am: Food Anim Pract 11:615-625.
9. Bolin SR, McClurkin AW, Cutlip RC, Coria MF: 1985a, Severe clinical disease induced in cattle persistently infected with noncytopathic bovine viral diarrhea virus by superinfection with cytopathic bovine viral diarrhea virus. Am J Vet Res 46:573-576.
10. Bolin SR, McClurkin AW, Cutlip RC et al: 1985b, Response of cattle persistently infected with noncytopathic bovine viral diarrhea virus to vaccination for bovine viral diarrhea and to subsequent challenge exposure with cytopathic bovine viral diarrhea virus. Am J Vet Res 46:2467-2470.
11. Bolin SR, Ridpath JF: 1995, Assessment of protection from systemic infection or disease afforded by low to intermediate titers of passively acquired neutralizing antibody against bovine viral diarrhea virus in calves. Am J Vet Res 56:755-759.
12. Bolin SR, Ridpath JF: 1996, Glycoprotein E2 of bovine viral diarrhea virus expressed in insect cells provides calves limited protection from systemic infection and disease. Arch Virol 141:1463-1477.
13. Bolin SR, Ridpath JF: 1998, Prevalence of bovine viral diarrhea virus genotypes and antibody against those viral genotypes in fetal bovine serum. J Vet Diagn Invest 10:135-139.
14. Brock KV, Chase CCL: 2000, Development of a fetal challenge method for the evaluation of bovine diarrhea virus vaccines. Vet Microbiol 77:209-214.
15. Brock KV, Cortese VS: 2001, Experimental fetal challenge using type II bovine viral diarrhea virus in cattle vaccinated with modified-live virus vaccine. Vet Therapeutics 2:354-360.
16. Brownlie J, Clarke MC, Hooper, LB et al.: 1995, Protection of the bovine fetus from bovine viral diarrhoea virus by means of a new inactivated vaccine. Vet Rec 137:58-62.
17. Brownlie J, Clarke MC, Howard CJ: 1984, Experimental production of fatal mucosal disease in cattle. Vet Rec 114:535-536.
18. Brownlie J, Clarke MC, Howard CJ: 1989, Experimental infection of cattle in early pregnancy with a cytopathic strain of bovine viral diarrhoea virus. Res Vet Sci 46:307-311.
19. Bruschke, CJM, Moormann RJM, van Oirschot JT, van Rijn PA: 1997, A subunit vaccine based on glycoprotein E2 of bovine viral diarrhea virus induces fetal protection in sheep against homologous challenge. Vaccine 15:1940-1945.
20. Bruschke CJM, van Oirschot JT, van Rijn PA: 1999, An experimental multivalent bovine virus diarrhea virus E2 subunit vaccine and two experimental conventionally inactivated vaccines induce partial fetal protection in sheep. Vaccine 17:1983-1991.
21. Carman S, van Dreumel T, Ridpath J, et al.: 1998, Severe acute bovine viral diarrhea in Ontario, 1993-1995. J Vet Diagn Invest 10:27-35.
22. Collett MS: 1996, Genomic structure of BVDV. In: Bovine Viral Diarrhea Virus: A 50 year review. Cornell University Press, Ithaca, NY.
23. Compendium of Veterinary Products: 2003, Seventh Edition. North American Compendiums, Port Huron, MI, pp. 302-309.
24. Cortese VS, Ellis J, Whittaker R: 1997, BVDV virus transmission following attenuated vaccines to BVDV seronegative cattle. Large Animal Pract, September/October pp. 18-24.
25. Cortese VS, Grooms DL, Ellis J, et al.: 1998c, Protection of pregnant cattle and their fetuses against infection with bovine viral diarrhea virus type 1 by use of a modified-live virus vaccine. Am J Vet Res 59:1409-1413.
26. Cortese VS, West KH, Hassard LE, et al.: 1998b, Clinical and immunological responses of vaccinated and unvaccinated calves to infection with a virulent type II isolate of bovine viral diarrhea virus. J Am Vet Med Assoc 213:1312-1319.
27. Cortese VS, Whittaker R, Ellis J, et al: 1998a, Specificity and duration of neutralizing antibodies induced in healthy cattle after administration of a modified-live virus vaccine against bovine viral diarrhea. Am J Vet Res 59:848-850.
28. Dean HJ, Leyh R: 1999, Cross-protective efficacy of a bovine viral diarrhea virus (BVDV) type 1 vaccine against BVDV type 2 challenge. Vaccine 17:1117-1124.
29. Done JT, Terlecki S, Richardson C, et al.: 1980, Bovine virus diarrhoea-mucosal disease virus: pathogenicity for the fetal calf following maternal infection. Vet Rec 106:473-479.
30. Dubois WR, Cooper VL, Duffy JC, et al.: 2000, A preliminary evaluation of the effect of vaccination with modified live viral diarrhea virus (BVDV) on detection of BVDV antigen in skin biopsies using immunohistochemical methods. Bovine Pract 34:98-100.
31. Duffel SJ, Sharp MW, Winkler CE, et al.: 1984, Bovine virus diarrhoea-mucosal disease virusinduced fetopathy in cattle: efficacy of prophylactic maternal pre-exposure. Vet Rec 114:558-561.
32. Elahi SM, Shen SH, Talbot BG, et al.: 1999, Recombinant adenoviruses expressing the E2 protein of bovine viral diarrhea virus induces humoral and cellular immune responses. FEMS Microbiol Letters 177:159-166.
33. Ellis J, West K, Cortese V, et al.: 2001, Effect of maternal antibodies on induction and persistence of vaccine-induced immune responses against bovine viral diarrhea virus type II in young calves. J Am Vet Med Assoc 219:351-356.
34. Endsley JJ, Quade MJ, Terhaar B, Roth JA: 2002, Bovine viral diarrhea virus type 1-and type 2-specific bovine T lymphocyte-subset responses following modified-live virus vaccination. Vet Therapeutics 3:364-372.
35. Flores EF, Ridpath JF, Weiblen R, et al.: 2002, Phylogenetic analysis of Brazilian bovine viral diarrhea virus type 2 (BVDV-2) isolates: eveidence for a subgenotype within BVDV-2. Virus Research 87:51-60.
36. Frey HR, Eicken K, Grummer B, Kenklies S, et al.: 2002, Foetal protection against bovine viral diarrhoea virus after two-step vaccination. J Vet Med B 49:489-493.
37. Fulton RW, Burge LJ: 2000, Bovine viral diarrhea virus types 1 and 2 antibody response in calves receiving modified live virus or inactivated vaccines. Vaccine 19:267-274.
38. Fulton RW, Confer AWW, Burge LJ, et al.: 1995, Antibody responses by cattle after vaccination with commercial viral vaccines containing bovine herpesvirus-1, bovine viral diarrhea virus, parainfluenza-3 virus, and bovine respiratory syncytial virus immunogens and subsequent revaccination at day 140. Vaccine 13:725-733.
39. Fulton RW, Cook BJ, Step DL, et al.: 2002b, Evaluation of health status of calves and the impact on feedlot performance: assessment of a retained ownership program for postweaning calves. Can J Vet Res 66:173-180.
40. Fulton RW, Purdy CW, Confer AW, et al: 2000a, Bovine viral diarrhea type 1 and 2 infections in feeder calves with respiratory disease: interactions with Pasteurella spp., parainfluenza-3 virus and bovine respiratory syncytial virus. Can J Vet Res 64:151-159.
41. Fulton RW, Ridpath JF, Confer AW, et al.: 2003a, Bovine viral diarrhoea virus antigenic diversity: impact on disease and vaccination programs. Biologicals. In press.
42. Fulton RW, Ridpath JF, Saliki JT, et al.: 2002a, Bovine viral diarrhea virus (BVDV) 1b: Predominant subtype in calves in calves with respiratory disease. Can J Vet Res 66:181-190.
43. Fulton RW, Saliki JT, Burge LJ, et al: 1997, Neutralizing antibodies to type 1 and 2 bovine viral diarrhea viruses: detection by inhibition of viral cytopathology and infectivity by immunoperoxidase assay. Clin Diagn Immunol 4:380-383.
44. Fulton RW, Saliki JT, Burge LJ, Payton ME: 2003c, Humoral immune response and assessment of vaccine virus shedding in calves receiving modified live virus vaccines containing bovine herpesvirus-1 and bovine viral diarrhoea virus 1a. J Vet Med B 50:31.
45. Fulton RW, Saliki JT, Confer AW, et al: 2000b, Bovine viral diarrhea virus cytopathic and noncytopathic biotypes and type 1 and 2 genotypes in diagnostic laboratory accessions: clinical and necropsy samples from cattle. J Vet Diagn Invest 12:33-38.
46. Fulton RW, Step DL, Ridpath JF, et al.: 2003b, Response of calves persistently infected with noncytopathic bovine viral diarrhea virus (BVDV) subtype 1b after vaccination with heterologous BVDV strains in modified live virus vaccines and Mannheimia haemolytica bacterin-toxoid. Vaccine 21:2980-2985.
47. Giangaspero M, Harasawa, R: 1999, Ovine pestiviruses: Their taxonomic status revealed by palindromic nucleotide substitutions. Vet Microbiol 70:33-39.
48. Grooms DL, Brock KV, Ward LA: 1998, Detection of cytopathic bovine viral diarrhea virus in the ovaries of cattle following immunization with a modified live bovine viral diarrhea virus vaccine. J Vet Diagn Invest 10:130-134.
49. Grooms DL, Coe P: 2002, Neutralizing antibody responses in preconditioned calves following vaccination for respiratory viruses. Vet Therapeutics 3:119-127.
50. Harpin S, Hurley DJ, Mbikay M, et al.: 1999, Vaccination of cattle with a DNA plasmid encoding the bovine viral diarrhoea virus major glycoprotein E2. J Gen Virol 80:3137-3144.
51. Howard CJ, Clarke MC, Brownlie J: 1989, Protection against respiratory infection with bovine virus diarrhoea virus by passively acquired antibody. Vet Microbiol 19:195-203.
52. Howard CJ, Clarke MC, Sopp P, Brownlie J: 1994, Systemic vaccination with inactivated bovine virus diarrhoea virus protects against respiratory challenge. Vet Microbiol 42:171-179.
53. Jones L, Van Campen H, Xu ZC, et al.: 2001, Comparison of neutralizing antibodies to type 1a, 1b, and 2 bovine viral diarrhea virus from experimentally infected and vaccinated cattle. Bovine Pract 35:137-140.
54. Kirkpatrick J, Fulton RW, Burge LJ, et al.: 2001, Passively transferred immunity in newborn calves, rate of antibody decay, and effect on subsequent vaccination with modified live virus vaccine. Bovine Pract 35:47-55.
55. Lambert G: 1973, Bovine viral diarrhea: Prophylaxis and postvaccinal reactions. J Am Vet Med Assoc 163:874-876.
56. Liess B, Orban S, Frey HR, et al.: 1984, Studies on transplacental transmissability of a bovine virus diarrhoea (BVD) vaccine virus in cattle II. Inoculation of pregnant cows without detectable neutralizing antibodies to BVD virus 90-229 days before parturition (51st to 190th day of gestation). Zbl Vet Med B 31:669-681.
57. Makoschey B, Janssen MGJ, Vrijenhoek MP, et al.: 2001, An inactivated bovine virus diarrhoea virus (BVDV) type 1 vaccine affords protection against BVDV type 2. Vaccine 19:3261-3268.
58. McClurkin AW, Littledike ET, Cutlip RC, et al.: 1984, Production of cattle immunotolerant to bovine viral diarrhea virus. Can J Comp Med 48:156-161.
59. McKercher DG, Saito JK, Crenshaw GL, et al.: 1968, Complications in cattle following vaccination with a combined bovine viral diarrhea-infectious bovine rhinotracheitis vaccine. J Am Vet Med Assoc 152:1621-1624.
60. Nobiron I, Thompson I, Brownlie, J, Collins ME: 2003, DNA vaccination against bovine viral diarrhoea virus induces humoral and cellular responses in cattle with evidence for protection against viral challenge. Vaccine. In press.
61. Orban S, Liess B, Hafez SM, et al.: 1983, Studies on transplacental transmissibility of a bovine virus diarrhoea (BVDV) vaccine virus in cattle. I. Inoculation of pregnant cows 15 to 90 days before parturition (190th to 265th day of gestation). Zbl Vet Med B 30:619-634.
62. Patel JR, Shilleto RW, Williams J, Alexander DCS: 2002, Prevention of transplacental infection of bovine foetus by bovine viral diarrhoea virus through vaccination. Arch Virol 147:2453-2463.
63. Pellerin C, vanden Hurk J, Lecomte J, Tijssen P: 1994, Identification of a new group of bovine viral diarrhea virus strains associated with severe outbreaks and high mortalities. Virology 203:260-268.
64. Perino LJ, Hunsaker BD: 1997, A review of bovine respiratory disease vaccine field efficacy. Bovine Pract 31:59-66.
65. Peter CP, Tyler DE, Ramsey FK: 1967, Characterization of a condition following vaccination with bovine virus diarrhea vaccine. J Am Vet Med Assoc 150:46-52.
66. Phillips RM, Heuschele WP, Todd JD: 1975, Evaluation of a bovine viral diarrhea vaccine produced in a porcine kidney cell line. J Am Vet Med Assoc 36:135-140.
67. Potgeiter LND: 1995, Immunology of bovine viral diarrhea virus. Vet Clin North Am: Food Anim Pract 11:501-520.
68. Ridpath JF, Bolin SR: 1995, Delayed onset postvaccinal mucosal disease as a result of genetic recombination between genotype 1 and genotype 2 BVDV. Virology 212:259-262.
69. Ridpath JF, Bolin SR: 1998, Differentiation of types 1a, 1b and 2 bovine viral diarrhea virus (BVDV) by PCR. Mol Cell Prob 12:101-106.
70. Ridpath JF, Bolin SR, Dubovi EJ: 1994, Segregation of bovine viral diarrhea virus into genotypes. Virology 205:66-74.
71. Ridpath JF, Neill JD, Endsley J, Roth JA: 2003, Effect of passive immunity on the development of a protective immune response against bovine viral diarrhea virus in calves. Am J Vet Res 64:65-69.
72. Rosner SF: 1968, Complications following vaccination of cattle against infectious bovine rhinotracheitis, bovine viral diarrhea-mucosal disease, and parainfluenza type 3. J Am Vet Med Assoc 152:898-902.
73. Roth JA, Kaeberle ML: 1983, Suppression of neutrophil and lymphocyte function induced by a vaccinal strain of bovine viral diarrhea virus with and without the administration of ACTH. Am J Vet Res 44:2366-2372.
74. Shimazaki T, Nakamura S, Taguchi K, Inoue Y, et al.: 2003, Efficacy of bovine viral diarrhea vaccine used in Japan against bovine viral diarrhea virus type 2 strain 890. J Vet Med Sci 65: 263-266.
75. Studer E, Bertoni G, Candrian U: 2002, Detection and characterization of pestivirus contaminations in human live viral vaccines. Biologicals 30:289-296.
76. Talens LT, Beckenhauer WH, Thurber ET, et al.: 1989, Efficacy of viral components of a nonabortigenic vaccine for prevention of respiratory and reproductive system diseases in cattle. J Am Vet Med Assoc 194:1273-1280.
77. van Campen H, Vorpahl P, Huzurbazar S, et al.: 2000, Evidence for bovine viral diarrhea virus type 2 (BVDV)-associated disease in beef herds vaccinated with a modified-live type 1 BVDV vaccine. J Vet Diagn Invest 12:263-265.
78. van Oirschot JT, Bruschke CJM, van Rijn PA: 1999, Vaccination of cattle against bovine viral diarrhoea. Vet Microbiol 64:169-183.
79. van Rijn PA, van Gennip HGP, Leenderste CH, et al.: 1997, Subdivision of the Pestivirus genus based on envelope glycoprotein E2. Virology 237:337-348.